-transparent.png){kind=logo}
Serum IgD levels were quantified in a large population of individuals with a variety of atopic and/or pulmonary disorders. As a group, patients with allergic bronchopulmonary aspergillosis (ABPA) have markedly elevated (5.03 mg%) serum IgD when compared with serum IgD levels from either normal individuals (2.17 mg%) or patients with a variety of pulmonary and/or atopic disorders. Evidence is presented suggesting that the increased serum IgD levels in ABPA patients are not necessarily related to a hyper-IgE or panhyperimmunoglobulinemia common to most of all these patients, but is rather associated with an additional quantitative difference in the immunological responsiveness of some of these individuals. An understanding of why these patients produce supranormal levels of IgD may reveal the basis for inducing an IgD antibody response and subsequently help in elucidating the biological function(s) of IgD.
M I Luster, and
G A Leslie, and
E J Bardana
July 2015,
Mycoses,
M I Luster, and
G A Leslie, and
E J Bardana
September 2019,
Mycoses,
M I Luster, and
G A Leslie, and
E J Bardana
January 1974,
International archives of allergy and applied immunology,
M I Luster, and
G A Leslie, and
E J Bardana
October 2003,
The European respiratory journal,
M I Luster, and
G A Leslie, and
E J Bardana
October 1981,
The Journal of allergy and clinical immunology,
M I Luster, and
G A Leslie, and
E J Bardana
June 1995,
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
M I Luster, and
G A Leslie, and
E J Bardana
December 1977,
Clinical and experimental immunology,
M I Luster, and
G A Leslie, and
E J Bardana
June 1990,
Annals of allergy,
M I Luster, and
G A Leslie, and
E J Bardana
January 2017,
Annals of thoracic medicine,
M I Luster, and
G A Leslie, and
E J Bardana
January 1994,
Chest,
